News

RSV is causing thousands of infant deaths in India yearly, yet remains underdiagnosed. Experts stress the urgent need for ...
Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...
The percentage of parents seeking waivers for vaccinations for religious or other reasons has nearly doubled from 2020 to ...
If I have sounded like a broken record these past months, it is because these developments in American public health are as ...
“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...
Adults as young as 50 may now qualify for an respiratory synctial virus vaccine if they have certain health conditions.
Each year, almost 200,000 adults 65 and older are hospitalized due to RSV, and an estimated 14,000 of those cases result in ...
A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa's private sector but not yet in public clinics. The country's advisory group on ...
Shifts in RSV testing methodology, which were accelerated by changes related to the COVID-19 pandemic, mirror shifts seen in ...
SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the ...
British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...